Mangrove Partners Master Fund Ltd. 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 12:06 pm Sale |
2021-01-26 | 13G | Sierra Oncology, Inc. SRRA |
Mangrove Partners Master Fund Ltd. | 548,869 4.800% |
-38,595 (-6.57%) |
Filing |
| 2021-02-16 12:00 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Mangrove Partners Master Fund Ltd. | 587,464 5.100% |
587,464 (New Position) |
Filing |